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Stage 1AAbstract Introduction: Endometrial cancer is the commonest gynecological cancer mostly affect-
ing women in the postmenopausal age group. There is a debate regarding the need of pelvic lym-
phadenectomy in managing stage 1A diagnosed preoperatively, we try to evaluate this need.
Objective: To evaluate the role of pelvic lymphadenectomy in stage 1A endometrial carcinoma
diagnosed preoperatively by pelvic ultrasonography and CT scan as microscopic invasion of pelvic
lymph nodes will not be seen by this imaging technique.
Methods: 60 Cases of endometrial carcinoma diagnosed by fractional curettage and proved to be
stage 1A preoperatively by clinical examination, vaginal US and CT scan (negative myometrial
invasion, ascites, LN spread and local spread) underwent total abdominal hysterectomy with sal-
pingo-oopherectomy, peritoneal wash for cytology, omentectomy and pelvic lymphadenectomy
(external iliac and obturator groups) after written informed consent. Histopathology of the uterus,
tubes, ovaries, omentum and cytology of peritoneal wash were done for surgical staging, in addition
histopathology of pelvic LN was done.
Results: Histopathology of the cases revealed the following: 52 cases were endometrioid adenocar-
cinoma distributed as follows: 10 patients were grade 1, 35 patients were grade 2 and 7 patients were
grade 3. Eight cases were serous papillary adenocarcinoma, 3 of them were grade 1 and 5 cases were
grade 2. As regards myometrial invasion 9 cases of endometrioid carcinoma show invasion, 1 of grade
1, 3 of grade 2 and 5 of grade 3 in comparison to 4 cases of papillary serous adenocarcinoma 1 of grade
1 and 3 of grade 2, so 13 cases have been proved by histopathology to have myometrial invasion.
Conclusion: There is no need for lymphadenectomy in stage 1A diagnosed preoperatively using CT
scan and vaginal US, preventing high risk surgical intervention in this early stage.
ª 2013 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.
Table 1 Relation between pathological types of endometrial
carcinoma and age, myometrial invasion and metastatic affec-
tion of pelvic lymph nodes.
Types of
endometrial
cancer
Number Mean
age
Myometrial
invasion
Lymph
node metastasis
Yes No Yes No
Endometrioid G1 10 49.4465 1 9 0 10
Endometrioid G2 35 59.5434 3 32 3 32
Endometrioid G3 7 60.345 5 2 6 1
Serous papillary G1 3 61.143 1 2 0 3
Serous papillary G2 5 67.453 3 2 3 2
Total 60 59.58618 13 47 12 48
Table 2 Relation between pathological types of endometrial
carcinoma and age.
Types of endometrial cancer Number Mean age
Endometrioid G1 10 49.4 ± 6.98
Endometrioid G2 35 59.5 ± 7.11
Endometrioid G3 7 60.3 ± 5.88
Serous papillary G1 3 61.1 ± 6.07
Serous papillary G2 5 67.4 ± 5.77
Total 60 59.6 ± 5.22
F 2.98
P 0.107
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Endometrial cancer is the commonest gynecological cancer
mostly affecting women in the postmenopausal age group.
Rates vary around the world but are highest in white women
in Western populations.1
While in Africa, south Asia and developing countries, it
ranks the second after cervix cancer.2 Risk factors for corpus
cancer can be classiﬁed as endogenous, with prolonged high
estrogen levels, and exogenous.
Endogenous risk factors include obesity, early menarche,
late menopause, low parity, polycystic ovary syndrome, estro-
gen secreting tumors, and family history, particularly the
Lynch type II syndrome. The data are inconclusive for diabe-
tes mellitus and immune deﬁciency.3 Exogenous risk factors
include noncyclical estrogen replacement therapy, tamoxifen
therapy, sequential oral contraception, diet, and previous radi-
ation therapy.4 The median age for diagnosis of endometrial
carcinoma is about 60 years. Abnormal bleeding is the most
common presenting symptom, but a few patients are asymp-
tomatic.5 Because there is no adequate screening test for endo-
metrial cancer, it is common practice to sample the
endometrium of postmenopausal women who experience
abnormal bleeding.6 Endometrial carcinoma is divided into
numerous histologic categories based on cell type. The most
common cell type, endometrioid, accounts for 75% to 80%
of cases.7 Other types include papillary serous adenocarcinoma
and the less common clear cell types.8 The International
Federation of Obstetricians and Gynecologists 1988 staging
system for tumors of the uterine corpus is as follows:
IA G123 Invasion conﬁned to the endometrium
IB G123 Invasion conﬁned to the inner half of the
myometrium
IC G123 Invasion to outer half of the myometrium
IIA Endocervical glandular involvement only
IIB Cervical stromal invasion
IIIA Tumor invades uterine serosa, adnexa, and/or positive
peritoneal cytology
IIIB Vaginal metastasis
IIIC Metastasis to pelvic or paraaortic lymph nodes
IVA Tumor invasion of the bladder and/or bowel mucosa
IVB Distant metastasis including intra-abdominal or ingui-
nal node metastases.9
Preoperative staging includes vaginal US and CT scan to
detect local spread and pelvic and paraaortic LN spread. There
is a debate regarding the need of pelvic lymphadenectomy in
managing stage 1A diagnosed preoperatively, we try to evalu-
ate this need.
2. Aim
The aim was to evaluate the role of pelvic lymphadenectomy in
stage 1A endometrial carcinoma diagnosed preoperatively by
pelvic ultrasonography and CT scan.
3. Patients and methods
Following approval by our institutional ethics committee, 60
cases of endometrial carcinoma diagnosed by fractionalcurettage and proved to be stage 1A preoperatively by clinical
examination, vaginal US and CT scan (negative myometrial
invasion, ascites, LN spread and local spread) underwent total
abdominal hysterectomy with salpingo-oopherectomy, perito-
neal wash for cytology, omentectomy and pelvic lymphadenec-
tomy (external iliac and obturator groups) after written
informed consent. Histopathology of the uterus, tubes,
ovaries, omentum and cytology of peritoneal wash were done
for surgical staging, in addition to histopathology of pelvic LN
to show percentage of microscopic LN spread or macroscopic
spread not detected by CT.
4. Results
Histopathology of the cases revealed the following: 52 cases
were endometrioid adenocarcinoma distributed as follows:
10 were grade 1, 35 grade 2 and 7 were grade 3. 8 cases were
serous papillary adenocarcinoma, 3 of them were grade 1 and
5 were grade 2. As regards myometrial invasion 9 cases of
endometrioid carcinoma show invasion, 1 of grade 1, 3 of
grade 2 and 5 of grade 3 in comparison to 4 cases of papil-
lary serous adenocarcinoma 1 of grade 1 and 3 of grade 2,
so 13 cases have been proved by histopathology to have myo-
metrial invasion. As regards histopathology of pelvic LN 12
cases out of 60 have been proved to have metastatic lesion
3 of them were serous papillary adenocarcinoma grade 2
and 9 were endometrioid, 3 grade 2 and 6 grade 3. As regards
cytology of peritoneal ﬂuid all cases were negative for atypi-
cal cells. Also all cases showed neither spread to tubes and
ovaries nor omental affection.
Table 3 Relation between pathological types of endometrial carcinoma and myometrial invasion and metastatic affection of pelvic
lymph nodes.
Types of endometrial cancer Number Myometrial invasion Lymph node metastasis
Yes No Yes No
No. % No. % No. % No. %
Endometrioid G1 10 1 10.0 9 90.0 0 0.0 10 100.0
Endometrioid G2 35 3 8.6 32 91.4 3 8.6 32 91.4
Endometrioid G3 7 5 71.4 2 28.6 6 85.7 1 14.3
Serous papillary G1 3 1 33.3 2 66.7 0 0.0 3 100.0
Serous papillary G2 5 3 60.0 2 40.0 3 60.0 2 40.0
Total 60 13 21.7 47 78.3 12 20.0 48 80.0
X2 19.22 20.3
P 0.0074* 0.0012*
P Z–test for yes only 0.215 0.265
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Graph 1 Demonstrates distribution of cases with myometrial
invasion in relation to different histological grades of the different
pathological types.
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Graph 2 Demonstrates distribution of cases with lymph node
metastasis in relation to different histological grades of the
different pathological types.
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The Data were collected and entered into the personal com-
puter. Statistical analysis was done using Statistical Package
for Social Sciences (SPSS/version 17) software.
Arithmetic mean, standard deviation, number and percent,
ANOV-test were used to compare between different types of
endometrial cancer group regarding age. For categorized
parameters, chai square test was used to compare between
the positive and negative in the same diagnosis, while Z test
was used to compare between the positive cases in each type
of endometrial cancer. The level of signiﬁcance was 0.05.
There is no signiﬁcant difference between different histolog-
ical grades of pathological types of endometrial carcinoma and
age (p= 0.107) (Table 1).
There was a signiﬁcant difference as regards myometrial
invasion between cases with myometrial invasion and cases
without (p= 0.0074) (Table 2), also there was a signiﬁcant
difference as regards lymph node metastasis between cases that
show positive lymph node affection and cases without(p= 0.0012), while there was no signiﬁcant difference between
the different histological grades of the different pathological
types in cases with myometrial invasion (p= 0.215) (Table 3),
also no signiﬁcant difference between the different histological
grades of the different pathological types in cases with lymph
nodes metastasis was found (p= 0.265). (Graphs 1 and 2).
5. Discussion
The strongest argument for routine staging is the avoidance of
pelvic radiation therapy following thorough nodal assessment
and conﬁrmation of node-negative disease and low risk status.
In the absence of nodal disease, recurrence risk is low and
overall survival is high, with no radiation or with the substitu-
tion of vaginal vault brachytherapy. This has encouraged
many gynecologic oncologists to move toward performing
286 H.H.A.H. El Sokkaryroutine surgical staging including pelvic and para-aortic
lymphadenectomy for nearly all patients with endometrial can-
cer, so we select positive nodal cases for adjuvant
radiotherapy.10
It is suggested that lymphadenectomy improves the
carcinoma-related survival and the recurrence-free survival
in high-risk endometrioid adenocarcinoma patients.11,12
Conversely, lymphadenectomy does not appear to beneﬁt
patients with grade 1 and 2 endometrioid lesions with myome-
trial invasion <50% and primary tumor diameter <2 cm.13
However, lymphadenectomy is a highly risky surgical
intervention that needs skilled surgeon and has many serious
complications as great vessel injury, so we study the need of
this procedure in stage 1a which was diagnosed preoperatively
using fractional curettage, vaginal US to detect myometrial
invasion and CT scan to detect lymph node affection, abdom-
inal and pelvic metastasis, but some cases may have micro-
scopic or macroscopic LN affection which is not seen in CT
scan and so we cannot assess the need of lymphadenectomy
in these cases without doing sampling of LN and fresh frozen
biopsy in this early stage.
Although our results showed that there was no signiﬁcant
lymph node affection in this early stage diagnosed preopera-
tively using CT scan and vaginal US, 12 cases out of 60 are
missed so we need to do pelvic lymph node sampling and fresh
frozen biopsy should be taken from all cases and proceed to
pelvic lymphadenectomy if lymph nodes are affected, also
there was no signiﬁcant myometrial invasion. In addition our
results showed that there was no speciﬁc histological grade
in the different pathological types that is associated with
lymph node metastasis or myometrial invasion.
From this study, we can conclude that pelvic lymphadenec-
tomy is not needed in stages 1A endometrial carcinoma
diagnosed preoperatively using CT scan, vaginal US and
conﬁrmed intraoperatively by lymph node sampling and fresh
frozen biopsy to prevent missing cases with lymph node
affection.
6. Conclusion
Pelvic lymphadenectomy is not needed in stages 1A endome-
trial carcinoma diagnosed preoperatively using CT scan, vagi-
nal US and conﬁrmed intraoperatively by lymph node
sampling and fresh frozen biopsy.Conﬂict of interest
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